ScholarWorks@Korea University: Yoon, Young Kyung

Detailed Information

Yoon, Young Kyung (윤영경)

College of Medicine (Department of Medical Science)

Research Area

Tel 02-920-5341
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

COVID19:8||Korea:5||Bacteremia:4||Infection control:4||Methicillinresistant Staphylococcus aureus:4||Streptococcus pneumoniae:4||pneumonia:3||Endocarditis:3||risk factors:3||SARSCoV2:3||Acinetobacter baumannii:3||Candidemia:2||Safety:2||Antibiotics:2||Klebsiella pneumoniae:2||Vancomycinresistant enterococci:2||Mortality:2||Pneumococcal infections:2||Risk factor:2||Hospitals:2||Hepatitis B virus:2||epidemiology:2||Pregnancy:2||Treatment outcome:2||infection control:2||Candida:2||Emergency preparedness:1||Intraabdominal Infections:1||Multidrugresistant:1||Echinocandins:1||multidrug resistant:1||IL10:1||Resource:1||Lactococcus garvieae:1||Chronic kidney disease:1||Leukocytes:1||bloodstream infections:1||antifungal therapy:1||Latent syphilis:1||Ceftriaxone:1||treatment outcome:1||COLONIZATION:1||Hepatitis A:1||ICUs:1||genotype:1||Disease Outbreaks:1||aspergillosis:1||Diagnosis:1||Enterococcus:1||Intraabdominal infections:1||infectious diseases:1||otolaryngology:1||synergistic effect:1||Clinical pathways:1||Liver Abscess:1||Antimicrobial Susceptibility:1||gastrointestinal microbiome:1||Clostridioides difficile:1||immunoassay:1||Casecontrol study:1||nosocomial infections:1||Guideline:1||EpsteinBarr virus:1||Acute pyelonephritis:1||Streptococcus sanguinis:1||Middle east respiratory syndrome coronavirus:1||Rheumatoid arthritis:1||Creactive protein:1||Neutropenia:1||outcome:1||mortality:1||PSEUDOMONASVESICULARIS:1||GENNOV:1||CHILD:1||Pure red cell aplasia:1||cDNA microarray:1||Biosensor:1||Endogenous fungal endophthalmitis:1||colistin:1||meropenem:1||Surveillance:1||ENT:1||Antimicrobial resistance:1||Guidelines:1||<:1||/p>:1||Severe acute respiratory syndrome coronavirus 2:1||Turnaround time:1||PowerChek SFTSV Realtime PCR kit:1||Infectious arthritis:1||opportunistic infections:1||procalcitonin:1||Streptococcus agalactiae:1||Ertapenem:1||Mycobacterium abscessus:1||Clinical severity:1||Clostridium difficile:1||Length of stay:1||Bromocriptine:1||KLEBSIELLATREVISANII:1||IDENTIFICATION:1||Hemolytic anemia:1||timeseries analysis:1||Erythrocyte:1||plasmid:1||SHV12:1||Baths:1||Chlorhexidine gluconate:1||Nocardia farcinica:1||Antimicrobial stewardship program:1||A. baumannii<:1||Micafungin:1||Huaiyangshan banyangvirus:1||Gastrointestinal Carriage:1||Epidemiology:1||Respiratory virus:1||Pharyngitis:1||pulmonary tuberculosis:1||Extendedspectrum betalactamase:1||Infective endocarditis:1||Quarantine:1||Procalcitonin:1||respiratory viruses:1||Bacteraemia:1||COMBNOV:1||SEPTICEMIA:1||Neurosurgery:1||prescription:1||severity:1||amphotericin B:1||Cell membrane:1||Multidrugresistance:1||Digital health care monitoring system:1||CRAB:1||antimicrobial peptide:1||viral diseases:1||public:1||Healthcare Crisis Resource Management:1||Anidulafungin:1||SFTSQS kit:1||Antiviral:1||Hypervirulent:1||Active surveillance:1||multiplex:1||Antibiotic use:1||Rhinosinusitis:1||Prevention:1||Piperacillin/tazobactam:1||Pseudomonas aeruginosa:1||Dendritic cells:1||Risk factors:1||Health care workers:1||Personal protective equipment:1||Administration:1||Oral:1||blood cultures:1||Gummatous neurosyphilis:1||septic shock:1||INFECTION:1||alanine aminotransferase:1||voriconazole:1||casecontrol study:1||Legionella pneumophila:1||Outbreak:1||tigecycline:1||Adverse Event:1||antibiotics:1||Health care facilities:1||Treatment:1||systematic review:1||serotyping:1||sputum:1||Effectiveness:1||Corynebacterium striatum:1||pulmonary edema:1||Influenza:1||Hepatitis C virus:1||Escherichia coli:1||Multidrug resistance organism:1||Staffing:1||MAB1843:1||Pulmonary embolism:1||Haemothorax:1||Occupational exposure:1||Heart valve prosthesis:1||Listeria monocytogenes:1||Pyogenic:1||Malignancy:1||bacteremia:1||outcomes:1||HIV negative:1||Suprasellar Tumor:1||Autonomic Dysfunction:1||Biomarker:1||Thrombophlebitis:1||alphahemolysin:1||Clinical practice guidelines:1||Intensive care unit:1||Interrupted timeseries analysis:1||.:1||Pandemics:1||Neonate:1||Healthcare Systems:1||Pandemic:1||manpower and services:1||Stewardship:1||SFTS virus:1||Performance:1||Multidrugresistant bacteria:1||23valent pneumococcal vaccine:1||Timeseries analysis:1||Endophthalmitis:1||Tonsillitis:1||pulmonary lymphomatoid granulomatosis:1||Neoagarooligosaccharides:1||Sepsis:1||COX2:1||ESBL:1||Th1 polarization:1||Antibacterial agents:1||Treatment outcomes:1||Disinfection:1||Empyema:1||Immunocompromised host:1||Spondylitis:1||Discitis:1||candidaemia:1||coinfection:1||blood transfusion:1||severe sepsis:1||Central Fever:1||antibacterial agent:1||Anemia:1||Corticosteroid:1||immunocompromised host:1||minimum inhibitory concentration:1||Novel coronavirus disease 2019 (COVID19):1||spread:1||Acquisition:1||brain abscess:1||Vaccine:1||pituitary disorders:1||carbapenemresistance:1||sepsis:1||intensive care units:1||Coronavirus disease 2019:1||Health Resources:1||Measurement:1||Efficacy:1||fecal microbiota transplantation:1||Prosthesisrelated infections:1||multilocus sequence typing:1||HIV infection:1||Coinfection:1||A20:1||MAPK:1||Postexposure prophylaxis:1||Tuberculosis:1||catheterrelated infections:1||colonization:1||BACTEREMIA:1||communityacquired pneumonia:1||hepatitis A virus:1||morbidity:1||Infection Control:1||ureteral obstruction:1||Electrochemical impedance spectroscopy:1||Community treatment center:1||DHA1:1||empyema:1||AntiSARSCoV2 monoclonal antibody:1||respiratory medicine:1||antimicrobial peptides:1||p>:1||respiratory viral infections:1||

STATISTICS: Total View :6,943,194; Today View :9,267

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE